Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

Industrials Conglomerates
TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.


CSE:KETA - Post by User

TripSitter Clinic Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by biggonadson Feb 10, 2022 12:53pm
152 Views
Post# 34417212

Rocketing to $0.40s this week

Rocketing to $0.40s this weekTripSitter keeps rocketing, bouncing from the $0.20s to the $0.40s throughout this week. For those unfamiliar with TripSitter Clinics connecting patients with medical practitioners for at-home low-dose ketamine assisted therapies, I’d recommend checking this article: https://investortelegraph.com/meet-the-new-revolutionary-service-tripsitter/3024 2022 is definitely the year that Ketamine assisted therapies hit the mainstream.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities